August 8, 2022 |
*Mohinder Mann joins as Associate Medical Director *Nicole Moores joins as Associate Director, Pharma & Lifesciences *Sharron Woods joins as Associate Director, Animal Health Evoke Mind+Matter has continued to strengthen its global marcomms offering with the addition of three strategic associate level hires.
Mohinder Mann joins as Associate Medical Director
With over 20 years’ experience delivering medical strategy for big pharma (including medical roles at Ashfield Health and AstraZeneca), Mohinder’s remit includes the oversight of medical output and ensuring scientific and technical accuracy is applied across all communications.
Mohinder said of his appointment: “It has very much always been my belief that medical-marketing is at the core of successful healthcare brands. I am excited to join Evoke Mind+Matter who are aligned with this as an organisation by endeavouring to bring scientific rigour to every client they work with. Every team member very much believes in this ethos, and it’s been great to see the inclusivity for the role of medical when defining the brand strategy and outputs for our client’s brands.”
Nicole Moores joins as Associate Director, Pharma & Lifesciences
Nicole joins the Evoke Mind+Matter pharma global client services team with more than two decades’ consultancy and agency experience spanning senior roles at 90TEN, and deep experience in diabetes, disease awareness and patient behaviour.
Nicole said of her appointment: “It’s not often you get the chance to join an agency with a genuine passion to make a real difference to patient outcomes. Evoke Mind+Matter is this agency. And this is my passion too. What a great time to join! With the strategy and insights that comes with the new Evoke Mind+Matter I’m very excited to be part of a truly inspiring and talented team that focuses on building strong, lasting client partnerships where we work alongside each other for the greater good of making a difference to patients’ lives.”
Sharron Woods joins as Associate Director, Animal Health
Deeply passionate about the health and welfare of animals, Sharron joins Evoke Mind+Matter following a 15+ year career in animal health pharma that includes roles leading marketing teams Bayer Animal Health (now Elanco). Sharron is also an active committee member of the prestigious Veterinary Marketing Association.
Sharron said of her appointment: “Having worked with the animal health team at Evoke Mind+Matter for many years on the client side, I’ve been consistently impressed with the team’s knowledge, expertise and passion for the health and welfare of animals. I am eager to apply my own experience in the sector and help grow our impressive portfolio of global animal health clients even further.”
Evoke Mind+Matter launched a year ago with a fresh, fearless vision of what healthcare communications could be. It closed 2021 with £6m of new business, 200 percent growth in average client revenue, 60 new hires, investment in a new proprietary tech platform, Gravity, and a unique new proposition to make health more human™ by creating meaningful experiences driven by data and emotion to ultimately change behaviour.
Corrina Safeio, UK MD said of the recent appointments: “Our integrated offering has grown exponentially, and our ‘health first, sector second’ approach means we can deliver full-service capability from deep pharma to disease awareness and public health campaigns right through to animal health. We’re so excited to welcome Mohinder, Sharron and Nicole to our senior team, which reflects our ongoing commitment to recruiting the best talent in the industry to deliver game changing work that really matters for our clients and the patients (and animals!) we serve.”
This content was provided by Inizio
Latest Content from Inizio
Key insights from ASCO® 2026, including oncology trends, scientific highlights, and strategies for smarter congress engagement.
Across sessions, panels, and conversations on the ground in Denver, there was a noticeable shift in both mindset and momentum. Many of the themes discussed in previous years are now...
Inizio, the global commercialization partner to the health and life sciences industry, today announced the launch of Intelligent Congress – a connected, end-to-end solution designed to help pharma organizations maximize...
Integrated capabilities combining advanced analytics, pharmacy, and specialized talent to improve access, affordability, and adherence
Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the...
Discover how AI, analytics and real-world data are reshaping Medical Affairs.
Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.
Explore Inizio Medical's key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.
At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...
Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...
